skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines pertuzumabQuestion & answer

pertuzumab · Medicine question

What is the median elimination half-life of pertuzumab?

iatroX medicinesPublished 8 November 2026

The answer

Answer

The median elimination half-life of pertuzumab is 18 days.

Sources for this answer

Perjeta 420 mg Concentrate for Solution for InfusionRoche Products Limited · emc · SmPC §5.2 Pharmacokinetic properties · Version 22Document updated 16 June 2026

Sources checked 8 November 2026

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

pertuzumab

Read the wider context, including uses, precautions and the sources behind this medicine guide.

More questions about pertuzumab

Has the safety and efficacy of pertuzumab (Perjeta) been established in children and adolescents under 18?Have pharmacokinetic interactions been observed between pertuzumab and trastuzumab or docetaxel?Have specific animal fertility studies been performed with pertuzumab?How long is effective contraception required after the last dose of pertuzumab (Perjeta)?How much polysorbate 20 does each 14 ml vial of Perjeta (pertuzumab) contain?How should the infusion bag be mixed after diluting Perjeta (pertuzumab) concentrate?

Read the pertuzumab guide

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX